Natrofen (Cefprozil)

Cefprozil, the active ingredient in Natrofen, is a cephalosporin antibiotic presented as a tablet for oral use. It treats a range of bacterial infections, particularly in the respiratory tract, ear, throat and skin of adult and pediatric patients.

GNH USA supplies Natrofen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards, maintaining GMP‑certified manufacturing facilities, and providing reliable sourcing and comprehensive regulatory support for global healthcare providers through established logistics networks.

Cefprozil, a cephalosporin antibiotic, is used to treat bacterial infections affecting the respiratory tract, ear, throat and skin.

Acute bacterial sinusitis: clears infection, reduces sinus inflammation and associated symptoms. Acute otitis media: eradicates causative bacteria, relieving ear pain and fever. Pharyngitis: eliminates streptococcal organisms, improving throat pain and swallowing. Tonsillitis: treats bacterial tonsillar infection, decreasing swelling and discomfort. Acute bronchitis: combats bacterial pathogens in the lower airways, improving cough and sputum production. Skin and soft‑tissue infections: resolves cellulitis and wound infections, promoting healing.

Cefprozil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring shortly after dosing. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Clostridioides difficile‑associated diarrhea: colitis requiring medical attention. - Stevens‑Johnson syndrome: severe mucocutaneous blistering. - Blood dyscrasias: neutropenia or thrombocytopenia. - Hepatic enzyme elevation: abnormal liver function tests. - Renal impairment: reduced kidney function in susceptible individuals.

Before prescribing Natrofen, clinicians should consider several safety measures.

Assess renal function: adjust dose in patients with impaired renal clearance. Monitor for allergic reactions: discontinue if signs of hypersensitivity appear. Avoid use in patients with known cephalosporin allergy. Use with caution in pregnant or breastfeeding women: weigh benefits against potential risks. Store at room temperature: keep in the original container, protect from moisture and heat.

Cefprozil can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Probenecid: may increase cefprozil plasma concentrations, raising toxicity risk. - Anticoagulants (e.g., warfarin): can enhance anticoagulant effect, increasing bleeding risk. - Live bacterial vaccines: antibiotic may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in hormonal effectiveness. - Diuretics (e.g., furosemide): may increase risk of nephrotoxicity. - Macrolide antibiotics: additive gastrointestinal side effects may occur.